Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer
European Journal of Cardio-Thoracic Surgery, 09/01/09
Tirino V et al. – The authors have isolated and characterised a population of CD133–positive cells from NSCLC that is able to give rise to spheres and can act as tumour–initiating cells.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 73%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 72%
Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09
Relevance Score: 71%
Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09
Relevance Score: 70%
African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09
Relevance Score: 70%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
Lung Cancer, 12/10/09
Stimulation of Sphingosine 1 Phosphate Signaling as an Alveolar Cell Survival Strategy in Emphysema
American Journal of Respiratory and Critical Care Medicine, 12/09/09
Bronchiolar Progenitor Cells
Proceedings of the American Thoracic Society, 12/04/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Tissue diagnosis of new lung nodules in patients with a known malignancy
The American Journal of Surgery, 12/10/09
Stage I nonsmall cell lung cancer in patients aged >=75 years
Cancer, 12/10/09
Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer
Current Drug Targets, 12/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


